Ignite Creation Date:
2024-05-06 @ 11:15 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03471572
Status:
COMPLETED
Last Update Posted:
2019-12-18
First Post:
2018-03-14
Brief Title:
Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian Primary Peritoneal and Fallopian Tube Cancer Patients in India
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-21
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-14
First Submit QC Date:
March 14 2018
Study First Post Date:
2018-03-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-17
Last Update Post Date:
2019-12-18
Last Update Post Date Type:
ACTUAL